Financhill
Back

Penumbra Vs. Biomarin Pharmaceutical Industry Stock Comparison

Buy
55

PEN
Penumbra

Last Price:
195.54
Seasonality Move:
-1.82%
Sell
33

BMRN
Biomarin Pharmaceutical

Last Price:
71.13
Seasonality Move:
5.7%
Buy
55
Penumbra (PEN) is a Buy

Is Penumbra a Buy, Sell or Hold?

  • The current Penumbra [PEN] share price is $187.06. The Score for PEN is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • PEN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $70.55. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PEN Stock Price Chart

What is Penumbra's stock price today?

  • The Penumbra share price today is $187.06
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PEN is experiencing slight selling pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $70.55
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

PEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.98 Buy
Relative Strength Index (14 RSI): 43.15 Sell
Chaikin Money Flow: -195234 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (189.71 - 204.29) Sell
Bollinger Bands (100): (178.94 - 202.92) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.98 Sell
Relative Strength Index (14 RSI): 20.79 Sell
Chaikin Money Flow: 1035913 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (81.58 - 93.32) Sell
Bollinger Bands (100): (78.83 - 88.25) Sell

PEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 195.86 Sell
20-day SMA: 199.19 Sell
50-day SMA: 189.21 Sell
200-day SMA: 215.3 Sell
8-day EMA: 193.85 Sell
20-day EMA: 195.13 Sell
50-day EMA: 192.33 Sell
200-day EMA: 209.04 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.97 Sell
20-day SMA: 86.7 Sell
50-day SMA: 86.17 Sell
200-day SMA: 87.12 Sell
8-day EMA: 79.59 Sell
20-day EMA: 84.09 Sell
50-day EMA: 85.42 Sell
200-day EMA: 86.31 Sell

Penumbra Earnings Growth & PEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.25 per share, an increase this year of $0.59 per share, and an increase next year of $0.98 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Penumbra Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):